ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology

ALZAI HEALTH CORP. ANNOUNCES VALIDATION OF ITS AI-DRIVEN ALZHEIMERS DISEASE RISK SCREENING SOLUTION ON LARGE-SCALE U.S. PATIENT DATA

ALZAI HEALTH CORP. SIGNS STRATEGIC U.S. COMMERCIALIZATION AGREEMENT WITH CENTAURI HEALTH SOLUTIONS TO ADVANCE AI-DRIVEN ALZHEIMER’S RISK IDENTIFICATION

ALZAI HEALTH CORP. ANNOUNCES TSX VENTURE EXCHANGE LISTING

ALZAI HEALTH CORP. FILES FINAL PROSPECTUS IN CONNECTION WITH INITIAL PUBLIC OFFERING